Urology Times Innovation Celebration Video Series : Episode 23
Video
Urology Times 50 Innovations Series: Neobladder reconstruction
Author(s):
"It's not perfect; you have to sort of retrain it, and there are some downsides to it. But it's the closest that we can get to, essentially, an artificial bladder," says Eila C. Skinner, MD.
Video Player is loading.
Urology Times® is celebrating its 50th anniversary in 2022. To mark the occasion, we are high-lighting 50 of the top innovations and developments that have transformed the field of urology over the past 50 years. In this installment, Eila C. Skinner, MD, discusses neobladder reconstruction in patients undergoing radical cystectomy. Skinner is a urologic oncologist and Thomas A. Stamey research professor of urology at Stanford Health in Palo Alto, California.
Related Videos
How recombinant BCG could ease strain of supply issues
Katherine Chan, MD, on viral vs non-viral vectors in bladder cancer
John Taylor, III, MD, on novel options in NMIBC
Suzanne B. Merrill, MD, FACS, on EAP program for recombinant BCG
What a long-term study of patients undergoing RARC reveals about upstaging
Sima Porten, MD, on the increased risk of bladder cancer among firefighters
Jason Hafron, MD, predicts coming advancements in bladder cancer
Laura Bukavina, MD, on trial of radiation with concurrent sacituzumab govitecan in MIBC
Chad Reichard, MD, on the Expanded Access Program for recombinant BCG
Neeraja Tillu, MD, discusses predictors of upstaging following RARC for NMIBC
Related Content
